Beyond Longevity

In this episode of Beyond Longevity, Daphna speaks with Dr David Cox, a health journalist (BBC, The Guardian, The Telegraph, NBC News and others), who holds a PhD in neuroscience from the University of Cambridge and is the author of The Age Code, about how diet, ultra-processed foods and the modern food environment shape biological ageing.Dr David argues that the longevity conversation often focuses too heavily on future drug breakthroughs, supplements and biohacking, while overlooking lower-hanging fruit that could already have a meaningful impact on long-term health. He explains why reducing ultra-processed foods, increasing fibre intake and paying closer attention to micronutrients such as vitamin K may matter far more than many people realise.The conversation explores gut ageing and its relationship with immune ageing, possible drivers behind the rise in early-onset cancers, and practical lifestyle strategies that may support healthier ageing. These include slow cooking, eating more protein and calories earlier in the day, lowering dietary acid load through fruits, vegetables and herbs, and the role omega-3s may play in long-term health.Daphna and Dr David also discuss biological ageing tests, visceral fat, kidney health markers, the limitations of CGMs for the average person, exercise mimetics, affordability within longevity medicine, and whether governments should take a far more active role in tackling the everyday drivers of chronic disease and accelerated ageing.The Age Code: https://www.amazon.co.uk/dp/0008708878https://www.instagram.com/drdavidcoxhealthhttps://www.linkedin.com/in/dr-david-cox-6b21966600:00 Welcome and Guest Intro02:00 From PhD to Journalism03:17 Science Scepticism and Nuance05:22 Trust Crisis in Health06:44 Protein Hype vs Fibre07:40 Micronutrients Matter09:07 Inside The Age Code10:50 Early Onset Cancer Clues12:38 Gut Ageing Explained14:49 Ten Nutritional Stressors17:55 Ultra Processed Food Reality19:32 Personal Choice vs Policy23:33 Longevity Focus Misplaced25:00 Ageing Tests and Omega 327:39 Advice for Any Budget29:48 Sauna Protocols31:04 Metabolomics Health Snapshots33:16 Testing Anxiety and Rule of Three35:41 His Own Biomarker Wake Up37:41 Best and Overrated Biomarkers41:25 Exercise Mimetic Drugs Debate48:05 Government and Ageing Strategy50:23 Kitchen Takeaways and Seaweed53:18 Rapid Fire Round56:08 Final Reflections and Outro

Supplements promise a lot: mitochondrial support, better brain health, healthier gut function, anti-ageing benefits and more.But how much of that is real science, and how much is simply clever wording on a label?In this episode of Beyond Longevity, Dr Luke Bucci, PhD, Chief Scientific Officer at Juvenon, brings both a scientist’s eye and decades of experience in the supplement industry to one of the most confusing areas of longevity.Dr Luke explains the difference between a product being described as “science-backed” and one that is supported by meaningful human clinical evidence. He also discusses why the dose, form and standardisation of an ingredient matter, and why “fairy-dusting” fashionable ingredients into a formula can make a product sound far more proven than it really is.We talk about bioavailability, absorption, the gut microbiome, and why feeling stimulated is not the same as supporting mitochondrial health. Dr Luke also explains why creatine has moved beyond the gym, why blood flow and nitric oxide matter as we age, and how nutrients such as magnesium, vitamin D3, omega-3s, polyphenols and CoQ10 fit into a more thoughtful approach to supplementation.This is a practical and refreshingly honest conversation about how to read beyond the label, ask better questions, and think more clearly about what supplements can, and cannot, do.Links:Instagram: https://www.instagram.com/juvenonwellnessFacebook: https://www.facebook.com/Juvenon/Website: https://juvenon.com/00:00 Welcome and Guest Intro01:53 Dr Bucci Origin Story03:26 Science vs Marketing Today04:44 Science Backed vs Clinical09:14 Fairy Dusting Exposed11:05 Bioavailability Reality Check14:15 Standardisation and Sourcing22:03 Gut Microbiome Benefits24:30 Testing and Trial Periods27:33 Longevity Trend Explained30:35 Mitochondria 10134:14 Stimulants vs Real Energy40:47 Stimulant Band Aid Trap41:51 Creatine Beyond The Gym45:08 Creatine Dosing And Safety47:11 Creatine For Brain Ageing50:53 Why Blood Flow Declines53:42 Nitric Oxide Basics57:44 Arginine Silicate Explained01:04:45 Polyphenols And Nitrates01:06:53 My Essential Supplements01:11:36 Rapid Fire Wisdom01:13:49 Episode Takeaways

This week on Beyond Longevity, I am joined by Dr Herna de Wit, CEO and Founder of Omnisci Consulting, with a PhD in Biochemistry and an LLB in Law.Dr Herna brings a very unusual and valuable combination to the longevity conversation: deep scientific training, legal expertise and hands-on experience advising companies in the health, biotech and longevity space.Longevity is full of exciting science, but it is also a field where marketing can move faster than evidence. In this episode, we ask a simple but important question: how do we separate what is genuinely credible from what merely sounds convincing?Dr Herna shares her five-point “scientific sanity check” for evaluating longevity products, supplements and protocols. We discuss why human RCT data matters more than animal or cell studies, why dosage and bioavailability are often overlooked, what biological age clocks can and cannot tell us, and why safety, third-party testing, and regulatory discipline are essential in a fast-moving market.We also look at longevity from the perspective of investors and company builders. What are the red flags? What makes a claim scientifically weak? And why does defensible intellectual property matter far beyond simply having a patent?Dr Herna explains how companies can think more intelligently about protectability, including through delivery systems, synergistic formulations, data, know-how and clearer scientific positioning.The conversation then turns to South Africa, a market that many listeners may not immediately associate with longevity, but one that raises fascinating questions. We discuss medical tourism, scientific talent, regulatory realities, affordability and whether South Africa could carve out a distinctive role in the global healthspan conversation.Finally, we speak about one of the most important tensions in longevity: if the science advances, who actually gets access? Is longevity already becoming another layer of privilege, or can the field develop in a way that is more credible, more inclusive and more useful?This is a conversation about evidence, accountability and the future of a field that urgently needs both excitement and discipline.Links:https://www.linkedin.com/in/herna-de-wit-phd-llb/https://linktr.ee/drherna.omnisci00:00 Show Intro and Guest02:41 Dr Herna’s Unusual Path04:29 What She Does Today06:13 Five Point Science Audit11:17 Investor Red Flags15:31 IP Beyond Patents20:12 Open Science vs Profit24:35 Founder IP Strategy32:54 Global Longevity Hotspots33:42 South Africa Opportunity36:33 Access and Inequality43:12 Regulation and Innovation46:20 How to Work With Dr Herna50:02 Rapid Fire Questions52:20 Final Takeaways Outro

On Beyond Longevity, Dr Filippo Ongaro, medical doctor, entrepreneur, and strategic advisor, shares how nearly eight years working with astronauts at the European Space Agency shaped the way he thinks about ageing.In space, the body can lose muscle, bone and resilience at a frightening speed. Stress, sleep disruption, nutrition, movement and circadian misalignment are not lifestyle details. They become central medical issues. For Dr Filippo, space became a kind of accelerated ageing model, showing in fast-forward what happens when the systems that keep us strong begin to break down, and why exercise and nutrition are such powerful countermeasures.After leaving ESA, Dr Filippo opened one of Italy’s early anti-ageing and functional medicine centres. But over time, he came to believe that the biggest obstacle in longevity is not simply knowledge, testing, or more biomarkers. It is the behaviour gap. People often know what they should be doing. The harder question is why they do not follow through.Together with his wife Sonya, he shifted from one-to-one clinical work into education, coaching, professional training and strategic advisory, with a focus on making longevity more accessible, affordable and practical, including through pharmacy-based pathways.In this conversation, he argues that longevity should focus on healthspan, avoid overpromising, build trust, start earlier with younger people, and move beyond fear of death towards purpose, identity and the joy of lifelinks: www.metodo-ongaro.com https://www.linkedin.com/in/dr-filippo-ongaro/ Dr. Filippo Ongaro00:00 Welcome and Guest Intro02:53 From ESA to Longevity05:07 Space as Accelerated Ageing07:40 Countermeasures and Behaviour Gap09:53 Mindset Over Biohacking14:24 Mission Drives Discipline17:22 Delayed Gratification Science20:37 Building Anti-Ageing Practice22:11 Why People Don't Follow Through24:31 Who Wanted Anti-Ageing Help28:16 Pivot to Education at Scale31:53 Training Health Professionals32:24 Scaling Impact Through Partners33:27 Broadening the Audience34:36 Affordable Longevity Access37:11 Institutions and Mass Market40:14 Business Advice for Clinicians43:26 Hype, Trust, and PR45:07 Fear Versus Joy of Life47:16 Identity Driven Change53:24 Future of Longevity Market56:00 Healthspan Over Lifespan57:58 Rapid Fire and Wrap Up01:00:18 Final Episode Takeaways

Michael A. Clinton, former President of Hearst Magazines.Michael spent four decades at the top of the publishing world, including as President and Publishing Director of Hearst Magazines, before turning his attention to one of the biggest questions of our time. If many of us are likely to live longer than previous generations, how do we make the second half of life not just longer, but more intentional, productive and meaningful?In this episode of Beyond Longevity, Michael discusses the ideas behind his book ROAR and his framework for rethinking later life. ROAR stands for Reimagine, Own your numbers, Action plan and Relationships, and it became the foundation for Roar Forward, his B2B platform advising organisations on the fast-changing 50-plus consumer.The conversation explores why Michael believes we need to shift the language from “ageing” to “longevity”, how culture and business are slowly beginning to respond, and why institutions, employers and policymakers still have a long way to go.Michael also previews ideas from his new book, Longevity Nation, which looks at the people, companies and innovations reshaping what longer lives could mean. He raises important concerns about inequality, access and the growing number of products making claims that are not always backed by evidence.This is also a very personal conversation. Michael reflects on his working-class roots in Pittsburgh, the moment that changed how he thought about identity and reinvention, and why the longest chapter of life may be the one most people have planned for the least.The episode also touches on the economic power of the $8.3 trillion 50-plus consumer, why this market is still widely misunderstood, and the one longevity habit Michael believes anyone can begin with, regardless of income.Links:Longevity NationROAR forwardLinkedIn00:00 Welcome and Guest Intro02:19 Early Life and First Memory03:17 Ambition and Upbringing05:12 Finding His Career Path06:29 Hearst Lessons on Identity09:22 ROAR Framework Explained13:29 Longevity Economy for Business16:19 Language and Pro Age Messaging18:43 Brands and Countries Adapting21:55 Fear and Reinvention Mindset22:59 Purposeful Second Act23:38 Reimagineer Stories24:37 Why Longevity Nation27:33 Inequality and Access30:13 America and 100 Year Life33:18 Policy Gaps to Fix35:53 Hope Worries Takeaway40:16 Rapid Fire Round42:42 Longevity Habits and Myths45:05 Closing Reflections